ATE359761T1 - Unpolarer spray zur bukkalen anwendung die alkaloidderivate oder analgetika enthält - Google Patents

Unpolarer spray zur bukkalen anwendung die alkaloidderivate oder analgetika enthält

Info

Publication number
ATE359761T1
ATE359761T1 AT02016165T AT02016165T ATE359761T1 AT E359761 T1 ATE359761 T1 AT E359761T1 AT 02016165 T AT02016165 T AT 02016165T AT 02016165 T AT02016165 T AT 02016165T AT E359761 T1 ATE359761 T1 AT E359761T1
Authority
AT
Austria
Prior art keywords
analgesics
percent
use containing
alkaloid derivatives
containing alkaloid
Prior art date
Application number
AT02016165T
Other languages
English (en)
Inventor
Harry A Dugger Iii
Original Assignee
Novadel Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novadel Pharma Inc filed Critical Novadel Pharma Inc
Application granted granted Critical
Publication of ATE359761T1 publication Critical patent/ATE359761T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT02016165T 1996-04-12 1997-02-21 Unpolarer spray zur bukkalen anwendung die alkaloidderivate oder analgetika enthält ATE359761T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/631,175 US5955098A (en) 1996-04-12 1996-04-12 Buccal non polar spray or capsule

Publications (1)

Publication Number Publication Date
ATE359761T1 true ATE359761T1 (de) 2007-05-15

Family

ID=24530090

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97914780T ATE237308T1 (de) 1996-04-12 1997-02-21 Unpolarer spray oder kapsel zur bukkalen anwendung
AT02016165T ATE359761T1 (de) 1996-04-12 1997-02-21 Unpolarer spray zur bukkalen anwendung die alkaloidderivate oder analgetika enthält

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97914780T ATE237308T1 (de) 1996-04-12 1997-02-21 Unpolarer spray oder kapsel zur bukkalen anwendung

Country Status (10)

Country Link
US (1) US5955098A (de)
EP (2) EP1275374B1 (de)
AT (2) ATE237308T1 (de)
AU (1) AU2190797A (de)
CA (1) CA2252050C (de)
DE (2) DE69737637T2 (de)
DK (1) DK0904055T3 (de)
ES (2) ES2286180T3 (de)
PT (1) PT904055E (de)
WO (1) WO1997038663A2 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
ES2293875T3 (es) 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
AU6331299A (en) * 1998-10-02 2000-04-26 Jenapharm Gmbh & Co. Kg Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients
US6977083B1 (en) 1998-10-02 2005-12-20 Jenapharm Gmbh & Co. Kg Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
ES2316350T3 (es) * 1999-02-26 2009-04-16 SHIONOGI & CO., LTD. Capsulas blandas masticables con propiedades mejoradas de administracion y procedimiento para producirlas.
EP1189596A1 (de) * 1999-06-02 2002-03-27 Norbert Dr.med. Klöcker Pharmazeutische zusammensetzung zur nasalen anwendung von wasserlöslichen wirkstoffen
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
CN102600104B (zh) * 2002-04-25 2015-06-24 旗帜药物胶囊公司 可咀嚼的软胶囊
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US7069280B2 (en) 2002-12-06 2006-06-27 Sun Microsystems, Inc. Collection-tick mechanism for a collector based on the train algorithm
US7031990B2 (en) 2002-12-06 2006-04-18 Sun Microsystems, Inc. Combining external and intragenerational reference-processing in a garbage collector based on the train algorithm
US7085790B2 (en) 2002-12-06 2006-08-01 Sun Microsystems, Inc. Advancing cars in trains managed by a collector based on the train algorithm
JP4708795B2 (ja) * 2002-12-20 2011-06-22 ニコノヴァム エービー 物理的および化学的に安定なニコチン−含有粒状物質
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US7062519B2 (en) 2003-02-27 2006-06-13 Sun Microsystems, Inc. Incremental scanning of enormous objects to improve scheduling and pause-time behavior of garbage collection
KR20130116378A (ko) * 2004-02-17 2013-10-23 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
US20060018840A1 (en) * 2004-06-28 2006-01-26 Nektar Therapeutics Aerosolizable formulation comprising nicotine
US7620943B1 (en) 2004-06-30 2009-11-17 Sun Microsystems, Inc. Using class properties to segregate objects in a generation managed by the train algorithm
US7676801B1 (en) 2004-08-31 2010-03-09 Sun Microsystems, Inc. Scanning of evacuated objects in a generation managed by the train algorithm
AU2012200031B9 (en) * 2005-02-17 2014-03-27 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
AU2006214166B2 (en) 2005-02-17 2011-09-29 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
AU2006226509A1 (en) * 2005-03-22 2006-09-28 Niconovum Ab Use of an artificial sweetener to enhance absorption of nicotine
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
WO2006128022A2 (en) * 2005-05-25 2006-11-30 Transcept Pharmaceuticals, Inc. Solid compositions and methods for treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
WO2008037470A1 (en) * 2006-09-27 2008-04-03 Niconovum Ab Directional use
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
BRPI0811430A2 (pt) * 2007-05-10 2015-06-23 Novadel Pharma Inc Composições anti-insônia e processos
US20100008868A1 (en) * 2007-11-27 2010-01-14 Harry Dugger Sustained remission of atopic dermatitis
CA2756879A1 (en) * 2009-04-23 2010-10-28 Londonpharma Ltd. Sublingual pharmaceutical composition comprising a neutral oil
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
EP2504019A2 (de) 2009-11-25 2012-10-03 ArisGen SA Zusammensetzung zur verabreichung über die schleimhaut mit einem komplex aus einem peptid und einer kronenverbindung und/oder einem gegenion
GB2482868A (en) 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration
EP2526971A1 (de) 2011-05-25 2012-11-28 ArisGen SA Mukosale Freisetzung von Arzneimitteln
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
US20220312826A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Liquid mixtures of triglyceride and liquid nicotine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
DE3338978A1 (de) * 1982-10-29 1984-05-03 Basf Ag, 6700 Ludwigshafen Verapamil und gallopamil und ihre physiologisch vertraeglichen salze zur resorptiven anwendung auf den schleimhaeuten des mundes, des nasen-rachen-raums und des rektums
DE3246081A1 (de) * 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
ATE164080T1 (de) * 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
NZ243061A (en) * 1991-06-10 1993-09-27 Schering Corp Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
WO1995031182A1 (en) * 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils

Also Published As

Publication number Publication date
ES2200165T3 (es) 2004-03-01
ES2286180T3 (es) 2007-12-01
DE69737637D1 (de) 2007-05-31
DE69720988T2 (de) 2003-12-11
WO1997038663A2 (en) 1997-10-23
EP0904055A2 (de) 1999-03-31
EP1275374B1 (de) 2007-04-18
CA2252050A1 (en) 1997-10-23
DE69737637T2 (de) 2008-01-10
EP0904055B1 (de) 2003-04-16
PT904055E (pt) 2003-08-29
US5955098A (en) 1999-09-21
ATE237308T1 (de) 2003-05-15
EP1275374A1 (de) 2003-01-15
AU2190797A (en) 1997-11-07
CA2252050C (en) 2005-12-27
DE69720988D1 (de) 2003-05-22
WO1997038663A3 (en) 1998-02-05
DK0904055T3 (da) 2003-08-18

Similar Documents

Publication Publication Date Title
ATE359761T1 (de) Unpolarer spray zur bukkalen anwendung die alkaloidderivate oder analgetika enthält
EP0663401A4 (de) Morphinan-derivate und ihre medizinische verwendung.
CA2058428A1 (en) Analgesic formulations
HU9701448D0 (en) 1-substituted 1h-imidazo [4,5-c]quinolin-4-amines, intermediate and pharmaceutical compositions
WO1999007351A3 (en) Indole derivatives and their use as mcp-1 antagonists
EP1952802A3 (de) Oraler, polarer und nicht-polarer Spray bzw. Kapsel
CA2182981A1 (en) Sublingual or buccal pharmaceutical composition
CA2059263A1 (en) Composition comprising the (-) enantiomer of cis-4-amino-1-(2-hydromethyl-1,3-oxathiolan-5-yl)-(1h)-pyrimidine-2-one or an enriched composition thereof, and its uses as a pharmaceutical agent
WO1996040086A3 (en) Compositions and methods for topical administration of pharmaceutically active agents
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
WO2000016762A3 (en) Method for reducing nicotine dependency
CA2176604A1 (en) Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin
CA2382919A1 (en) Bicyclic imidazo-3-yl-amine derivatives
CA2024767A1 (en) Interferon-gamma receptor fragment and its production
IL129892A0 (en) Prodrug forms and new analogues of camptothecin and their use as medicaments
NZ240406A (en) Substituted indolizino [1,2-b]quinolin-9(11h)-one derivatives, pharmaceutical formulations and use as antiviral agents
HK1018783A1 (en) BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5 α-REDUCTASES INHIBITORS
AU5326598A (en) New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
BG105616A (en) Pharmaceutical compositions of analgesic effect
CA2192822A1 (en) Use of immunosuppressive agents for the treatment of schizophrenia
WO1999005103A3 (en) 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent
NO307496B1 (no) Anvendelse av en <delta>-opioid antagonist for fremstilling av et antitussivt middel
CA2087922A1 (en) 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparation process and antidepressant, nootropic and psychostimulant composition thereof
CA2006778A1 (en) Nifedipine pharmaceutical preparation
KR930019217A (ko) 종양 치료제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties